Clinical trial
Assessment of Long Term Treatment With Testosterone Undecanoate in Males With…
NCT00220298 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00220298 |
|---|---|
| Title | Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism |
| Official title | Open One-arm Study to Investigate Safety and Efficacy of Intramuscular Injections of 1000 mg Testosterone Undecanoate (TU) in Hypogonadal Men at Variable Intervals During a 136-week to 192-week Treatment Including Pharmacokinetics |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | Testosterone undecanoate (TU) - NebidoTM |
| Enrollment | 96 |
| Start date | Feb 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 30, 2014 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: